Vitrolife

Vitrolife Group is a global provider of medical devices and genetic testing solutions focused on reproductive health. Since its inception in 1994, the company has expanded through innovative research, product development, and strategic acquisitions. Vitrolife offers a comprehensive range of products and services that support the entire reproductive-health journey, aiming to improve treatment outcomes and patient access worldwide. The company is committed to sustainability and continuous improvement in its operations and offerings.

1.2k

3.68

2.83

— Vitrolife
%
Consumables45% Includes media and disposable devices for IVF treatments.
Technologies30% Comprises time-lapse systems and lasers for reproductive health.
Genetics25% Offers genetic testing and analysis services for reproductive health.

Vitrolife serves a diverse range of customers in the reproductive health sector, including fertility clinics,...

  • Fertility Clinicsprimary

    Purchase IVF products and technologies to improve treatment outcomes.

  • Hospitalssecondary

    Use genetic testing solutions for comprehensive reproductive care.

  • Healthcare Professionalssecondary

    Rely on advanced monitoring systems like EmbryoScope®.

Vitrolife operates in approximately 125 markets worldwide, with significant presence in the Americas, EMEA, and APAC...

  • •Operates in ~125 markets globally, with a strong presence in the Americas, EMEA, and APAC.
  • •Key markets include the US and China, where investments have led to market share gains.
  • •Manufacturing and operations are spread across Sweden, Spain, Brazil, the US, Denmark, and Japan.
  • •Global presence enables adaptation to regional market demands and customer needs.

Vitrolife's strategic priorities focus on owning the platform, innovating to expand leadership, accelerating growth in...

01
Own the platformmedium-term

To integrate products and services for better customer solutions.

02
Accelerate growth in key marketsshort-term

To increase market share and revenue.

Vitrolife faces several strategic and operational risks, including macroeconomic fluctuations, regulatory changes, and...

high

Macroeconomic fluctuations

Impact global demand and pricing strategies.

Materiality
high
high

Regulatory changes

Affect product approvals and market access.

Materiality
high
medium

Competitive pressures

Challenge market position and pricing.

Materiality
medium
Revenue recognition timing
Fair value measurements

Getinge

GETI-B.ST · Health Care

AddLife

ALIF-B.ST · Health Care

REVVITY, INC.

RVTY · Laboratory Analytical Instruments

METLIFE INC

MET · Life Insurance

BIOLIFE SOLUTIONS INC

BLFS · Electromedical & Electrotherapeutic Apparatus

Nightingale Health Oyj

HEALTH.HE · Health Information Services

: 11/08/2026